High tissue abundance of ANRIL in cancers is associated with aggressive clinicopathologic features such as high histological grade tumor size, advanced tumor-node-metastasis stage, and poor overall survival (22, 38, 40, 58, 78, 79, 83, 87, 89, 91–93). This evidence concerns the gene CDKN2B-AS1 and neoplasm.